{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:27:04Z","timestamp":1791901624060,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,2,11]],"date-time":"2012-02-11T00:00:00Z","timestamp":1328918400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s10875-012-9657-4","type":"journal-article","created":{"date-parts":[[2012,2,10]],"date-time":"2012-02-10T15:13:28Z","timestamp":1328886808000},"page":"540-550","source":"Crossref","is-referenced-by-count":7,"title":["Up Regulated Complement and Fc Receptors in Juvenile Idiopathic Arthritis and Correlation with Disease Phenotype"],"prefix":"10.1007","volume":"32","author":[{"given":"Kajsa E.","family":"Prokopec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillemor","family":"Berntson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"\u00d6man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Kleinau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,11]]},"reference":[{"issue":"2","key":"9657_CR1","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390\u20132.","journal-title":"J Rheumatol"},{"issue":"10","key":"9657_CR2","first-page":"2275","volume":"30","author":"L Berntson","year":"2003","unstructured":"Berntson L, Andersson Gare B, Fasth A, Herlin T, Kristinsson J, Lahdenne P, et al. Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria. J Rheumatol. 2003;30(10):2275\u201382.","journal-title":"J Rheumatol"},{"issue":"8","key":"9657_CR3","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/08820130802438057","volume":"37","author":"HM Habib","year":"2008","unstructured":"Habib HM, Mosaad YM, Youssef HM. Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis. Immunol Invest. 2008;37(8):849\u201357.","journal-title":"Immunol Invest"},{"key":"9657_CR4","doi-asserted-by":"crossref","unstructured":"Modesto C, Anton J, Rodriguez B, Bou R, Arnal C, Ros J, et al. Incidence and prevalence of juvenile idiopathic arthritis in Catalonia (Spain). Scand J Rheumatol. 39(6):472\u20139.","DOI":"10.3109\/03009741003742722"},{"issue":"1","key":"9657_CR5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/03009740601089259","volume":"36","author":"C Pruunsild","year":"2007","unstructured":"Pruunsild C, Uibo K, Liivamagi H, Tarraste S, Talvik T, Pelkonen P. Incidence of juvenile idiopathic arthritis in children in Estonia: a prospective population-based study. Scand J Rheumatol. 2007;36(1):7\u201313.","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"9657_CR6","first-page":"1829","volume":"31","author":"JM Low","year":"2004","unstructured":"Low JM, Chauhan AK, Kietz DA, Daud U, Pepmueller PH, Moore TL. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis. J Rheumatol. 2004;31(9):1829\u201333.","journal-title":"J Rheumatol"},{"issue":"2","key":"9657_CR7","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/rheumatology\/kei133","volume":"45","author":"P Dewint","year":"2006","unstructured":"Dewint P, Hoffman IE, Rogge S, Joos R, Union A, Dehoorne J, et al. Effect of age on prevalence of anticitrullinated protein\/peptide antibodies in polyarticular juvenile idiopathic arthritis. Rheumatology (Oxford). 2006;45(2):204\u20138.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"9657_CR8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0090-1229(88)90145-6","volume":"47","author":"GC Tsokos","year":"1988","unstructured":"Tsokos GC, Inghirami G, Pillemer SR, Mavridis A, Magilavy DB. Immunoregulatory aberrations in patients with polyarticular juvenile rheumatoid arthritis. Clin Immunol Immunopathol. 1988;47(1):62\u201374.","journal-title":"Clin Immunol Immunopathol"},{"issue":"3","key":"9657_CR9","first-page":"25","volume":"32","author":"TL Moore","year":"1982","unstructured":"Moore TL, Weiss TD. Immunologic studies in juvenile arthritis. Bull Rheum Dis. 1982;32(3):25\u20139.","journal-title":"Bull Rheum Dis"},{"issue":"1","key":"9657_CR10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-3083.2006.01859.x","volume":"65","author":"JM Low","year":"2007","unstructured":"Low JM, Chauhan AK, Moore TL. Abnormal kappa:lambda light chain ratio in circulating immune complexes as a marker for B cell activity in juvenile idiopathic arthritis. Scand J Immunol. 2007;65(1):76\u201383.","journal-title":"Scand J Immunol"},{"issue":"9","key":"9657_CR11","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1084\/jem.191.9.1611","volume":"191","author":"S Kleinau","year":"2000","unstructured":"Kleinau S, Martinsson P, Heyman B. Induction and suppression of collagen-induced arthritis is dependent on distinct fcgamma receptors. J Exp Med. 2000;191(9):1611\u20136.","journal-title":"J Exp Med"},{"issue":"23","key":"9657_CR12","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.2174\/1381612033454414","volume":"9","author":"S Kleinau","year":"2003","unstructured":"Kleinau S. The impact of Fc receptors on the development of autoimmune diseases. Curr Pharm Des. 2003;9(23):1861\u201370.","journal-title":"Curr Pharm Des"},{"issue":"3","key":"9657_CR13","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1046\/j.1365-2249.1999.00817.x","volume":"115","author":"I Torsteinsdottir","year":"1999","unstructured":"Torsteinsdottir I, Arvidson NG, Hallgren R, Hakansson L. Monocyte activation in rheumatoid arthritis (RA): increased integrin, Fc gamma and complement receptor expression and the effect of glucocorticoids. Clin Exp Immunol. 1999;115(3):554\u201360.","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"9657_CR14","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/rheumatology\/keh112","volume":"43","author":"AL Hepburn","year":"2004","unstructured":"Hepburn AL, Mason JC, Davies KA. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis. Rheumatology (Oxford). 2004;43(5):547\u201354.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"9657_CR15","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1186\/ar2206","volume":"9","author":"SE Magnusson","year":"2007","unstructured":"Magnusson SE, Engstrom M, Jacob U, Ulfgren AK, Kleinau S. High synovial expression of the inhibitory FcgammaRIIb in rheumatoid arthritis. Arthritis Res Ther. 2007;9(3):R51.","journal-title":"Arthritis Res Ther"},{"key":"9657_CR16","doi-asserted-by":"crossref","unstructured":"Prokopec KE, Rhodiner M, Matt P, Lindqvist U, Kleinau S. Down regulation of Fc and complement receptors on B cells in rheumatoid arthritis. Clin Immunol. 137(3):322\u20139.","DOI":"10.1016\/j.clim.2010.08.006"},{"issue":"1","key":"9657_CR17","first-page":"53","volume":"4","author":"JJ Miller 3rd","year":"1986","unstructured":"Miller 3rd JJ, Olds LC, Huene DB. Complement activation products and factors influencing phagocyte migration in synovial fluids from children with chronic arthritis. Clin Exp Rheumatol. 1986;4(1):53\u20136.","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"9657_CR18","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/art.1780291108","volume":"29","author":"TE Mollnes","year":"1986","unstructured":"Mollnes TE, Paus A. Complement activation in synovial fluid and tissue from patients with juvenile rheumatoid arthritis. Arthritis Rheum. 1986;29(11):1359\u201364.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"9657_CR19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/rheumatology\/39.2.189","volume":"39","author":"A Aggarwal","year":"2000","unstructured":"Aggarwal A, Bhardwaj A, Alam S, Misra R. Evidence for activation of the alternate complement pathway in patients with juvenile rheumatoid arthritis. Rheumatology (Oxford). 2000;39(2):189\u201392.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"9657_CR20","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.molimm.2008.09.026","volume":"46","author":"R Khera","year":"2009","unstructured":"Khera R, Das N. Complement receptor 1: disease associations and therapeutic implications. Mol Immunol. 2009;46(5):761\u201372.","journal-title":"Mol Immunol"},{"issue":"6","key":"9657_CR21","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.4049\/jimmunol.143.6.1755","volume":"143","author":"RH Carter","year":"1989","unstructured":"Carter RH, Fearon DT. Polymeric C3dg primes human B lymphocytes for proliferation induced by anti-IgM. J Immunol. 1989;143(6):1755\u201360.","journal-title":"J Immunol"},{"issue":"5247","key":"9657_CR22","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1126\/science.271.5247.348","volume":"271","author":"PW Dempsey","year":"1996","unstructured":"Dempsey PW, Allison ME, Akkaraju S, Goodnow CC, Fearon DT. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science. 1996;271(5247):348\u201350.","journal-title":"Science"},{"issue":"4","key":"9657_CR23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1084\/jem.190.4.585","volume":"190","author":"D Bharadwaj","year":"1999","unstructured":"Bharadwaj D, Stein MP, Volzer M, Mold C, Du Clos TW. The major receptor for C-reactive protein on leukocytes is fcgamma receptor II. J Exp Med. 1999;190(4):585\u201390.","journal-title":"J Exp Med"},{"issue":"7224","key":"9657_CR24","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/nature07468","volume":"456","author":"J Lu","year":"2008","unstructured":"Lu J, Marnell LL, Marjon KD, Mold C, Du Clos TW, Sun PD. Structural recognition and functional activation of FcgammaR by innate pentraxins. Nature. 2008;456(7224):989\u201392.","journal-title":"Nature"},{"issue":"7","key":"9657_CR25","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/art.24534","volume":"60","author":"TA Griffin","year":"2009","unstructured":"Griffin TA, Barnes MG, Ilowite NT, Olson JC, Sherry DD, Gottlieb BS, et al. Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets. Arthritis Rheum. 2009;60(7):2113\u201323.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"9657_CR26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1084\/jem.145.2.357","volume":"145","author":"AG Ehlenberger","year":"1977","unstructured":"Ehlenberger AG, Nussenzweig V. The role of membrane receptors for C3b and C3d in phagocytosis. J Exp Med. 1977;145(2):357\u201371.","journal-title":"J Exp Med"},{"issue":"4","key":"9657_CR27","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3109\/08923970902845768","volume":"31","author":"D Liu","year":"2009","unstructured":"Liu D, Niu ZX. The structure, genetic polymorphisms, expression and biological functions of complement receptor type 1 (CR1\/CD35). Immunopharmacol Immunotoxicol. 2009;31(4):524\u201335.","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"3","key":"9657_CR28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/ard.51.3.307","volume":"51","author":"D McCarthy","year":"1992","unstructured":"McCarthy D, Taylor MJ, Bernhagen J, Perry JD, Hamblin AS. Leucocyte integrin and CR1 expression on peripheral blood leucocytes of patients with rheumatoid arthritis. Ann Rheum Dis. 1992;51(3):307\u201312.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"9657_CR29","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1002\/art.24601","volume":"60","author":"MG Barnes","year":"2009","unstructured":"Barnes MG, Grom AA, Thompson SD, Griffin TA, Pavlidis P, Itert L, et al. Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis. Arthritis Rheum. 2009;60(7):2102\u201312.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"9657_CR30","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/intimm\/dxm132","volume":"20","author":"A Isaak","year":"2008","unstructured":"Isaak A, Gergely Jr P, Szekeres Z, Prechl J, Poor G, Erdei A, et al. Physiological up-regulation of inhibitory receptors Fc gamma RII and CR1 on memory B cells is lacking in SLE patients. Int Immunol. 2008;20(2):185\u201392.","journal-title":"Int Immunol"},{"issue":"2","key":"9657_CR31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1084\/jem.186.2.199","volume":"186","author":"U Martin","year":"1997","unstructured":"Martin U, Bock D, Arseniev L, Tornetta MA, Ames RS, Bautsch W, et al. The human C3a receptor is expressed on neutrophils and monocytes, but not on B or T lymphocytes. J Exp Med. 1997;186(2):199\u2013207.","journal-title":"J Exp Med"},{"issue":"1","key":"9657_CR32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-3083.1999.00455.x","volume":"49","author":"TA Funkhouser","year":"1999","unstructured":"Funkhouser TA, Vik DP. Complement receptor type 1 gene regulation: retinoic acid and cytosine arabinoside increase CR1 expression. Scand J Immunol. 1999;49(1):21\u20138.","journal-title":"Scand J Immunol"},{"issue":"6","key":"9657_CR33","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.4049\/jimmunol.175.6.3698","volume":"175","author":"M Honczarenko","year":"2005","unstructured":"Honczarenko M, Ratajczak MZ, Nicholson-Weller A, Silberstein LE. Complement C3a enhances CXCL12 (SDF-1)-mediated chemotaxis of bone marrow hematopoietic cells independently of C3a receptor. J Immunol. 2005;175(6):3698\u2013706.","journal-title":"J Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-012-9657-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-012-9657-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-012-9657-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T15:04:44Z","timestamp":1686755084000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-012-9657-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,11]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["9657"],"URL":"https:\/\/doi.org\/10.1007\/s10875-012-9657-4","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,11]]}}}